Related Experiment Video
Updated: Aug 7, 2026
10:04
Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
Functional characterization of the epidermal cholinergic system in vitro
Hjalmar Kurzen1, Carmen Henrich, Dirk Booken
1Department of Dermatology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany. hjalmar.kurzen@haut.ma.uni-heidelberg.de
The Journal of Investigative Dermatology
|July 1, 2006
Summary
Cholinergic drugs promote epidermal differentiation and proliferation by activating acetylcholine receptors (AChRs). Blocking AChRs with anticholinergic drugs severely impairs epidermal barrier function and cell adhesion, leading to apoptosis.
Area of Science:
- Dermatology
- Pharmacology
- Cell Biology
Background:
- Epidermal homeostasis relies on complex signaling pathways.
- Acetylcholine receptors (AChRs) are increasingly recognized for their roles beyond the nervous system.
- The specific function of epidermal AChRs in skin physiology remains to be fully elucidated.
Purpose of the Study:
- To investigate the impact of cholinergic and anticholinergic drugs on epidermal physiology.
- To determine the role of nicotinic (nAChR) and muscarinic (mAChR) acetylcholine receptors in epidermal differentiation, proliferation, and barrier function.
Main Methods:
- Utilized organotypic cocultures (OTCs) of epidermal cells.
- Administered cholinergic agonists and anticholinergic antagonists (mecamylamine, atropine, strychnine) for 7-14 days.
- Assessed epidermal differentiation, proliferation, barrier integrity, cell adhesion, and apoptosis.
Main Results:
- Blocking AChRs with anticholinergic drugs (mecamylamine, atropine, strychnine) completely inhibited epidermal differentiation and proliferation.
- Muscarinic AChR blockade (atropine) caused more severe delays than nicotinic AChR blockade (mecamylamine).
- Anticholinergic drug treatment led to lipid accumulation, impaired barrier function, acantholysis, reduced cell adhesion, and apoptosis; cholinergic stimulation improved epithelial thickness and maturation.
Conclusions:
- Epidermal acetylcholine receptors are critical regulators of epidermal homeostasis.
- Targeting epidermal AChRs with cholinergic drugs can enhance skin barrier function and promote epithelial maturation.
- Anticholinergic drug use can disrupt epidermal physiology, highlighting potential side effects on skin health.
Related Concept Videos
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
01:25Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
01:15Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:30Parasympathetic Signaling
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...